Article
Reporting amyloid beta levels <i>via</i> bioluminescence imaging with amyloid reservoirs in Alzheimer’s disease models
2021-06-07
Abstract excerpt
Bioluminescence imaging has changed daily practice in preclinical research of cancers and other diseases in the last decades; however, it has been rarely applied in preclinical research of Alzheimer’s disease (AD). In this report, we demonstrated that bioluminescence imaging could be used to report the levels of amyloid beta (Aβ) species in vivo. We hypothesized that AkaLumine, a newly discovered substrate for luc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b1307220-6a8e-59b3-a3f9-1ffca4d4fbe6
- DOI
- 10.1101/2021.06.05.447217
